Today news
The same in other media
24.04 - 19:03
Panic buying before covid-19 lockdown boosts pharma sales in March
Reading now: 718
NEW DELHI: Pharmaceutical sales rose 9% in March due to panic buying of medicines for chronic diseases ahead of the three-week lockdown, data from market research firm AIOCD-AWACS showed.
Sales in the India pharmaceutical market rose to ₹11,856 crore aided by robust sales of cardiac care, respiratory and anti-diabetes drugs as people rushed to stock up on medicines before the lockdown was imposed to curb the spread of novel coronavirus infection, or covid-19. “Despite the Covid crises, the IPM (India pharmaceutical market) registered a surprising growth of 8.9% in March 2020 with some evidence of panic buying in chronic medicines," the market research firm said.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|